PPARγ coactivator 1β/ERR ligand 1 is an ERR protein ligand, whose expression induces a high-energy expenditure and antagonizes obesity

被引:306
作者
Kamei, Y
Ohizumi, H
Fujitani, Y
Nemoto, T
Tanaka, T
Takahashi, N
Kawada, T
Miyoshi, M
Ezaki, O
Kakizuka, A [1 ]
机构
[1] Osaka Biosci Inst, Dept Mol Med Sci, Suita, Osaka 565, Japan
[2] Osaka Biosci Inst, Dept Mol Behav Biol, Suita, Osaka 565, Japan
[3] Kyoto Univ, Grad Sch Biostudies, Kyoto 6068501, Japan
[4] Univ Tokyo, Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Tokyo 1538904, Japan
[5] Univ Tokyo, Adv Sci & Technol Res Ctr, Dept Mol Biol & Med, Tokyo 1538904, Japan
[6] Biooriented Res Advancement Inst, Res Project Obes & Lipid Metab Regulat, Tokyo 1050001, Japan
[7] Kyoto Univ, Grad Sch Agr, Nutr Chem Lab, Kyoto 6068502, Japan
[8] Nara Womens Univ, Dept Environm Hlth, Nara 6308506, Japan
[9] Natl Inst Hlth & Nutr, Div Clin Nutr, Tokyo 1628636, Japan
关键词
D O I
10.1073/pnas.2135217100
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
A well balanced body energy budget controlled by limitation of calorie uptake and/or increment of energy expenditure, which is typically achieved by proper physical exercise, is most effective against obesity and diabetes mellitus. Recently, peroxisome proliferator-activated receptor (PPAR)gamma, a member of the nuclear receptor, and its cofactors have been shown to be involved in lipid metabolism and in the control of energy expenditure. Here we show that PPARgamma coactivator 1 (PGC-1) beta functions as ERRL1 (for ERR ligand 1), which can bind and activate orphan ERRS (estrogen receptor-related receptors) in vitro. Consistently, PGC-1beta/ERRL1 transgenic mice exhibit increased expression of the medium-chain acyl CoA dehydrogenase, a known ERR target and a pivotal enzyme of mitochondrial beta-oxidation in skeletal muscle. As a result, the PGC-1beta/ERRL1 mice show a state similar to an athlete; namely, the mice are hyperphagic and of elevated energy expenditure and are resistant to obesity induced by a high-fat diet or by a genetic abnormality. These results demonstrate that PGC-113/ERRLI can function as a protein ligand of ERR, and that its level contributes to the control of energy balance in vivo, and provide a strategy for developing novel antiobesity drugs.
引用
收藏
页码:12378 / 12383
页数:6
相关论文
共 25 条
[1]   PGC-l-related coactivator, a novel, serum-inducible coactivator of nuclear respiratory factor 1-dependent transcription in mammalian cells [J].
Andersson, U ;
Scarpulla, RC .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (11) :3738-3749
[2]   Isolation of a gene encoding a novel member of the nuclear receptor superfamily from the critical region of usher syndrome type IIa at 1q41 [J].
Eudy, JD ;
Yao, SF ;
Weston, MD ;
Ma-Edmonds, M ;
Talmadge, CB ;
Cheng, JJ ;
Kimberling, WJ ;
Sumegi, J .
GENOMICS, 1998, 50 (03) :382-384
[3]   Obesity in the new millennium [J].
Friedman, JM .
NATURE, 2000, 404 (6778) :632-634
[4]   IDENTIFICATION OF A NEW CLASS OF STEROID-HORMONE RECEPTORS [J].
GIGUERE, V ;
YANG, N ;
SEGUI, P ;
EVANS, RM .
NATURE, 1988, 331 (6151) :91-94
[5]  
Glass CK, 2000, GENE DEV, V14, P121
[6]   PGC-1 and PERC, coactivators of the estrogen receptor-related receptor γ [J].
Hentschke, M ;
Süsens, U ;
Borgmeyer, U .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 299 (05) :872-879
[7]   Hormone-independent transcriptional activation and coactivator binding by novel orphan nuclear receptor ERR3 [J].
Hong, H ;
Yang, L ;
Stallcup, MR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (32) :22618-22626
[8]   A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors [J].
Kamei, Y ;
Xu, L ;
Heinzel, T ;
Torchia, J ;
Kurokawa, R ;
Gloss, B ;
Lin, SC ;
Heyman, RA ;
Rose, DW ;
Glass, CK ;
Rosenfeld, MG .
CELL, 1996, 85 (03) :403-414
[9]  
KOMENAMI N, 1995, J NUTR SCI VITAMINOL, V41, P395, DOI 10.3177/jnsv.41.395
[10]   Peroxisome proliferator-activated receptor γ coactivator-1 promotes cardiac mitochondrial biogenesis [J].
Lehman, JJ ;
Barger, PM ;
Kovacs, A ;
Saffitz, JE ;
Medeiros, DM ;
Kelly, DP .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (07) :847-856